Henry Wellcome: building a pharmaceutical and philanthropic legacy

Henry Wellcome’s life connected an American childhood with a British pharmaceutical business and a lasting commitment to medical research. Born in Wisconsin in 1853, he moved to London in 1880 and founded Burroughs Wellcome & Company with Silas Burroughs. The company helped introduce medicines in tablet form to England; after Wellcome’s death, the capital he left for charitable work helped establish the Wellcome Trust. His career also encompassed research laboratories and an extensive collection of medical objects.

From Wisconsin to the pharmaceutical trade

Wellcome was born on 21 August 1853 in a frontier log cabin in what would later become Almond, Wisconsin. His parents were Mary Curtis Wellcome and the Reverend S. C. Wellcome, an itinerant missionary who travelled and preached in a covered wagon. The family’s religious life included a strong commitment to the temperance movement. As a teenager, Wellcome showed an early interest in medicine and marketing: aged 16, he advertised lemon juice as invisible ink in a Minnesota newspaper.

Wellcome’s route into business was practical as well as scientific. He trained in pharmacy at the Philadelphia College of Pharmacy, graduating in 1874, and moved to London in 1880. That year he established Burroughs Wellcome & Company with his colleague Silas Mainville Burroughs. Their partnership joined Wellcome’s commercial ambition to a new way of presenting medicines to practitioners and customers.

In 1884, the company introduced the sale of medicine in tablet form in England, using the trademark “Tabloid”. Medicines had previously been sold mostly as powders or liquids. Burroughs and Wellcome also marketed directly to doctors, including by providing free samples. These were concrete changes to the presentation and promotion of medicines, rather than simply a new company name in an already familiar trade.

Research alongside the business

Burroughs died in 1895, aged 48, leaving Wellcome in charge of the business. It flourished, and Wellcome established several associated research laboratories. The Wellcome Physiological Research Laboratories, established in 1894, reflected an interest in organising scientific investigation alongside pharmaceutical production. The company’s research work included tropical medicine, among other areas of healthcare.

In 1901 Wellcome married Gwendoline Maud Syrie Barnardo, daughter of the orphanage founder Thomas John Barnardo. They had a son, Henry Mounteney Wellcome, born in 1903. The marriage ended in separation in 1909, and Wellcome sued for divorce in 1915. In 1910 he had become a British subject. His business and philanthropic life therefore developed across national borders, but Britain was where he built his pharmaceutical enterprise and spent much of his later life.

In 1924, Wellcome brought his commercial and non-commercial activities together under The Wellcome Foundation Ltd. This arrangement connected the company’s business with a broader set of research and charitable interests. He was knighted in 1932 and was also made an honorary fellow of the Royal College of Surgeons of England that year.

A will, a trust and a collection

Wellcome died in London on 25 July 1936, aged 82, after an operation. In his will, he vested the company’s entire share capital in trustees, instructing them to use its income to further human and animal health. The Wellcome Trust was formed from this provision. It is not simply a gift made during his lifetime: the charitable structure grew from the terms he set for the company’s capital after his death.

The Trust’s work has included support for biomedical research, research training, public engagement and bioethics. Fellowships and grants have helped researchers develop their work, while funding has also supported efforts to translate research into health products. The trust’s resources and activities have changed over time. The Wellcome Foundation was eventually sold to GlaxoSmithKline, with the proceeds invested, and the Trust’s work developed beyond the original company structure.

Wellcome’s collecting was another substantial part of his legacy. He gathered objects connected with medicine, with the aim of creating a “Museum of Man”. By the time of his death, the collection included 125,000 medical objects among more than a million objects in total; much of the non-medical material was later dispersed. His archaeological interests included excavations at Jebel Moya in Sudan, where he employed thousands of people. The collection is now managed by the Science Museum, London, and objects are displayed in its Medicine: The Wellcome Galleries. The Wellcome Collection has also exhibited items from it, including in the exhibition “Medicine Man”, which ran from 2007 to 2022. The holdings are not simply the contents of a single free museum and library, but a much wider collection with a continuing public and research presence.

Why Henry Wellcome deserves a place in British Legacy

Wellcome’s British legacy rests on institutions and systems he helped put in place. After moving to London, he built a pharmaceutical company with Silas Burroughs that introduced tablets under the “Tabloid” trademark and developed direct marketing to doctors. He then extended the business’s work through research laboratories. That combination of pharmaceutical commerce and organised investigation gave his enterprise a reach beyond the sale of medicines, while his British subjecthood from 1910 makes clear that his connection to the country was more than a matter of doing business there.

His will is central to the continuing importance of his name. By assigning the company’s entire share capital to trustees for the benefit of human and animal health, Wellcome created the basis for charitable work that outlasted him. The Wellcome Trust’s subsequent support for research, training and public engagement has carried that bequest into fields beyond the company he founded. His collecting also left a substantial resource for museums and researchers: the objects are now cared for by the Science Museum, with some shown in its galleries and others presented through the Wellcome Collection. Together, the pharmaceutical business, research activity, charitable endowment and collections explain his specific place in Britain’s history of medicine and philanthropy.

Sources

Henry Wellcome — Wikipedia revision

Adapted in part from Henry Wellcome by Wikipedia contributors, under CC BY-SA 4.0. Text has been edited and combined with the existing article; this adapted text is shared under the same licence. Contributor history.